您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2010, Vol. 48 ›› Issue (11): 117-120.

• 论文 • 上一篇    下一篇

脾切除术治疗特发性血小板减少性紫癜75例预后分析

冯锐1,张海霞2,李红梅3   

  1. 1. 滨州医学院附属医院血液科, 山东 滨州 256600; 2.  滨州医学院附属医院药剂科, 山东 滨州 256600;
    3. 青岛大学医学院附属医院肿瘤中心, 山东 青岛 266003
  • 收稿日期:2010-08-20 出版日期:2010-11-16 发布日期:2010-11-16
  • 作者简介:冯锐(1975- ),男,主治医师,硕士研究生,主要从事血小板疾病的研究。

Splenectomy for idiopathic thrombocytopenic purpura: prognosis analysis of 75 cases

FENG Rui1, ZHANG Hai-xia2, LI Hong-mei3   

  1. 1.Department of Blood, The Affiliated Hospital of Binzhou Medical College, Binzhou 256600, Shandong, China;
    2. Department of Pharmacy, The Affiliated Hospital of Binzhou Medical College, Binzhou 256600, Shandong, China;
      3. Cancer Center, The Affiliated Hospital of Medical College of Qingdao University, Qingdao 266003, Shandong, China
  • Received:2010-08-20 Online:2010-11-16 Published:2010-11-16

摘要:

目的     探讨脾切除术治疗特发性血小板减少性紫癜(ITP)的疗效及术前临床指标对疗效的影响。 方法     回顾75例(男11例,女64例)脾切除ITP患者的临床资料,按照性别、年龄、病程、血小板计数、骨髓巨核细胞数目、脾脏大小、激素治疗效果进行分组,比较分析各项因素与脾切除疗效之间的关系。结果     75例中显效42例(56.0%),良效18例(24.0%),进步9例(12.0%),无效6例(8%),8例术后复发。有效率(显效+良效占总病例数的百分比)为80.0%;男、女患者有效率分别为81.8%(9/11)、79.7%(51/64),(P>0.05);脾脏肿大、无肿大患者有效率分别为80.3%、77.8%(P>0.05);40岁以下、40岁以上患者有效率分别为85.4%、70.4% (P<0.05);糖皮质激素治疗有效、治疗无效患者的脾切除有效率分别为85.2%、66.7% (P<0.05);骨髓巨核细胞密度≥(7~35)个/(3cm×1.5cm) 、< (7~35)个/(3cm×1.5cm)患者有效率分别为85.7%、63.2%(P<0.05); 术前血小板计数>20×109个/L、<20×109个/L患者有效率分别为86.0%、68.0%(P<0.05);病程6个月以下、6个月以上患者有效率分别为84.5%、64.7%(P<0.05)。结论     性别、脾脏是否肿大与脾切除术的疗效预测无关;年龄、病程、骨髓巨核细胞数、血小板计数、对糖皮质激素的治疗反应与脾切除术疗效的预测有明显相关性。

关键词: 特发性血小板减少性紫癜;脾切除术;预后分析

Abstract:

Objective      To investigate the efficacy of splenectomy on patients with idiopathic thrombocytopenic purpura(ITP), and the influence of the preoperative clinical indexes on the efficacy.Methods     Clinical data from 75 (11 men, 64 women) ITP patients with splenectomy were reviewed, and grouped according to the sex, age, course of disease, platelet count, megalokaryocyte number, spleen size, and treatment outcome of glucocorticoid. The relations of each factor with splenectomy efficacy were compared and analyzed.  Results     Among 75 cases, 42 with excellent response (56.0%), 18 with good response (24.0%), 9 with progression(12.0%),6 with no response(8%). 8 patients relapsed after surgery. The response rate (the percentage of cases with excellent and good response in all cases) was 80.0%. The response rates were 81.8% and 79.7% in male and female (P>0.05), 80.3% and 77.8% in patients with and without spleen enlargement (P>0.05), 85.4% and 70.4% in patients younger and older than 40 years(P<0.05), 85.2 % and 66.7% in patients responsive and irresponsive to glucocorticoid therapy (P<0.05), 85.7% and 63.2% in patients with the bone marrow megakaryocyte number ≥ and < 7-35/(3×1.5)cm2 (P<0.05), 86.0%and 68.0% in patients with preoperative platelet count > and <20×109/L (P<0.05), and 84.5% and 64.7% in the disease course below and over 6 months, respectively (P<0.05). Conclusion     There is no relation of splenectomy efficacy with the gender or spleen size. However, the age, course of disease, bone marrow megakaryocyte number, platelet count, and the response to glucocorticoid are obviously relative to the efficacy of splenectomy.

Key words: Idiopathic thrombocytopenic purpura;Splenectomy;Prognosis analysis

中图分类号: 

  • R725.6
[1] 周佳丽1,2,张岩1,王东明2,张艳2. Toll样受体4在小儿哮喘致病机制中的作用[J]. 山东大学学报(医学版), 2013, 51(06): 106-109.
[2] . 肺炎支原体下呼吸道感染的临床特征分析[J]. 山东大学学报(医学版), 2009, 47(9): 125-128.
[3] . nAChRα7在条件免疫反应治疗小鼠支气管哮喘中的作用机制[J]. 山东大学学报(医学版), 2009, 47(7): 16-20.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!